Catalyst Wire Dossier Catalyst Wire Dossier

rhGDF-5

recombinant human growth differentiation factor-5 · DePuy Spine
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for rhGDF-5, covering 2016-01-27 to 2016-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration [Phase 2]

See pricing